Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery

Scandinavian Journal of Surgery

Volumn 96, Issue 4, 2007, Pages 314-318

  Suojaranta Ylinen, Raili T ^a   Vento, A E ^a   Patila T ^a   Kukkonen, S I ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Arginine vasopressin; Cardiac surgery; Cardiopulmonary bypass; Mortality; Norepinephrine; Outcome; Vasodilatory shock

Indexed keywords

ARGIPRESSIN; DOBUTAMINE; DOPAMINE; LEVOSIMENDAN; MILRINONE; NORADRENALIN; VASOPRESSIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART SURGERY; HEMODYNAMICS; HUMAN; INFECTION; INTENSIVE CARE UNIT; KIDNEY DISEASE; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; RISK FACTOR; SHOCK; SURGICAL PATIENT; VASODILATORY SHOCK;

EID: 37749038064     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690709600410     Document Type: Article

References (32)

1. Kirklin JK: Prospects for understanding eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 1991;51:529-531
2. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, Smith CR Jr, Rose EA, Landry DW, Oz MC: Management of vasodilatory shock after cardiac surgery. Identification of predisposing factors and use of novel pressor agent. J Thorac Cardiovasc Surg 1998;116:973-980
3. Chernow B, Roth BL: Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock 1986;18:141-155
4. Podrid PJ, Fusch T, Candinas R: Role of the symphathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990; 82 (suppl 1):1-103
5. Velissaris T, Tang ATM, Murray M, Mehta RL, Wood PJ, Hett DA, Ohri SK: A prospective randomized study to evaluate stress response during beating-heart and conventional coronary revascularization. Ann Thorac Surg 2004;78:506-512
6. Lindner KH, Dirks B, Strohmenger H-U, Prengel AW, Lindner IM, Lurie KG: Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. The Lancet 1997;349 (9051):535-537
7. Dünser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001;93:7-13
8. Morales DL, Gregg D, Helman DN, Williams MR, Naka Y, Landry DW, Oz MC: Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 2000; 69:102-106
9. Treschan TA, Petrs J: The vasopressin system. Anesthesiology 2006;105;599-612
10. Guidelines 2005 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7:2: Management of cardiac arrest. Resuscitation 2005;112:IV-58-IV-66
11. Rozenfield V, Cheng JWM: The role of vasopressin in the treatment of vasodilation in shock states. Ann Pharmacother 2000;34:250-254
12. Salzman AL, Vromen A, Denenberg A, Szabo C: K-ATP-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic shock. Am J Physiol 1997;272:H688-H694
13. Lindner KH, Strohmenger HU, Ensinger H, Hetzel WD, Ahnefeld FW, Georgieff M: Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992;77:662-668
14. Fox AW, May RE, Mitch WE: Comparison of peptide and non-peptide receptor-mediated responses in rat-tail artery. J Cardiovasc Pharmacol 1992;20:282-289
15. Oyoma H, Suzuki Y, Satoh S, Kajita Y, Takayasu M,Shibuya M, Sukita K: Role of nitric oxide in the cerebral vasodilatory responses to vasopressin and oxytocin in dogs. J Cereb Blood Flow. Metab 1993;13:285-90
16. Luckner G, Dünster MW, Jochberger S,Mayr VD, Wenzel V, Ulmer H, Schmid S, knotzer H, Pajk W, Hasibeder W, Mayr AJ, Friesenecker B: Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005;33:2659-2666
17. Pätilä T, Kukkonen S, Vento A, Pettilä V, Suojaranta-Ylinen R: Relation of the Sequential Organ Failure Assessment Score to Morbidity and Mortality After Cardiac Surgery. Ann Thorac Surg 2006;82:2072-2078
18. Nashef SAM, Roques F, Michel P, Gauducheau ME, Lemeshow S, Salomon R: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-Thorac Surg 1999; 16:9-13
19. Roques F, Nashef SAM, Gauducheau ME, de Vincentris C, Baudet E, Cortina I, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salomon R, Thulin L: Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardio-Thorac Surg 1999;15:816-823
20. Vincent JL, Moreno R, Takala J, Wallats S, de Mendonca A Bruining H, Reinhard CK, Suter P, Thijs LD: The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-710
21. Okamura T, Ayajaki K, Fujioka H, Toda N: Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. J Hypertension 1999;17:673-678
22. Wenzel V, Lindner KH, Baubin MA, Voelckel W: Vasopressin decreases endogenous catecholamine plasma levels during cardiopulmonary resuscitation in pigs. Crit Care Med 2000; 28:1096-1100
23. Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-582
24. Ryan TA, Rady MY, Bashour CA, Marvin L, Lytle B, Norman S: Predictors of outcome in cardiac surgical patients with prolonged intensive care stay. Chest 1997;112:1035-1042
25. Beale RJ, Hollenberg SM, Vicent J-L, Parrillo JE:. Vasopressor and inotropic support in septic shock: An evidence-based review. Crit Care Med 2004;32 (suppl):S455-S465
26. Dünster MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR: Arginine vasopressin in advanced vasodilatory shock, a prospective, randomized, controlled study. Circulation 2003;107:2313-2319
27. Albert M, Losser M-R, Hayon D, Faivre V, Payen D: Systemic and renal macro-and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med 2004;32:1891-1898
28. Morimatsu H, Uchino S, Chung J, Bellamo R: Norepinephrine for hypotensive vasodilatation after cardiac surgery: impact on renal function. Intensiv Care Med 2003;29:1106-1112
29. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT: Renal dysfunction after myocardial revascularisation: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 1998;128:194-203
30. Kantrowitz A, Wasfie T, Freed PS, Rubenfire M, Wajszczuk W, Schork A: Intra-aortic balloon pumping 1967 through 1982: Analysis of complications in 733 patients. Am J Cardiol 1986; 57:976-983
31. Lepelletier D, Perron S, Bizouarn P, Caillon J, Drugeon H, Michaud J-L, Duveau D: Surgical-site infection after cardiac surgery:incidence, microbiology, and risk factors. Infect Control Hosp Epidemiol 2005;26:466-472
32. Landry DW, Oliver JA: Mechanisms of disease: the pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-595